Behind the News: Health Care Havoc w/ Adam Gaffney
Jacobin Radio
00:00
Rethinking Pharmaceuticals and Public Health
This chapter examines the intricate relationship between drug companies and the FDA, arguing that corporate interests often overshadow public health in drug approvals. It advocates for reforming funding models to ensure publicly funded pharmaceuticals remain accessible while enhancing oversight of biomedical innovations.
Transcript
Play full episode
